Sentieon
Pre-clinicalSentieon develops a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency and fast turnaround time.
Founded
2014
Focus
AI / Machine LearningGenetics & GenomicsDiagnostics
About
Sentieon develops a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency and fast turnaround time.
Funding History
3Total raised: $85M
Series C$55MIntel CapitalJun 15, 2021
Series B$20MUndisclosedJun 15, 2018
Series A$10MUndisclosedJun 15, 2016
Company Info
TypePrivate
Founded2014
LocationSanta Clara, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile